By GREGORY ZELLER // New vaccines produced in part by a progressive Long Island biotech could significantly increase the efficacy of existing cancer treatments. The potential breakthrough – detailed this…
Vaccinations are ramping up and the pandemic is winding down, but COVID-19 continues to reshape the world around us. And myriad Long Island forces – large and small, corporate and…
By GREGORY ZELLER // It’s been a big week for one of Long Island’s boldest biotechs. Applied DNA Sciences, a Stony Brook-based leader in polymerase chain reaction-based DNA manufacturing, has…
By GREGORY ZELLER // With scientists around the world racing toward a COVID-19 vaccine, serums manufactured by a Long Island biotech are showing significant promise – both medically and economically….
By GREGORY ZELLER // An ambitious Long Island biotech is reporting exciting progress in a two-front battle against the raging novel coronavirus. Stony Brook-based Applied DNA Sciences on Tuesday announced…
By GREGORY ZELLER // With preliminary lab tests looking good, an innovative Long Island biotech is rushing a quintet of potential COVID-19 vaccines overseas. Stony Brook-based Applied DNA Sciences announced…
By GREGORY ZELLER // Just weeks after announcing an expanded international collaboration targeting the menacing novel coronavirus, Applied DNA Sciences is preparing to mass-produce four potential vaccines. Leveraging the Stony…
Just a word or two: Welcome to Friday, dear readers, as we wrap up another busy workweek and look forward to another well-earned weekend. It’s Feb. 21 out there,…
By GREGORY ZELLER // Look out, coronavirus – Applied DNA is coming for you. Adding to its growing portfolio of cutting-edge Polymerase Chain Reaction-based projects, Stony Brook-based Applied DNA Sciences…
By GREGORY ZELLER // Mark another impressive victory for LineaRX, this time in a two-front battle against cancer. The Stony Brook-based biotech with innovation in its DNA (literally) has lent…